Publications (31) Publications de JOSE PEREZ DEL PALACIO

2024

  1. Assessment of Untargeted Metabolomics by Hydrophilic Interaction Liquid Chromatography−Mass Spectrometry to Define Breast Cancer Liquid Biopsy-Based Biomarkers in Plasma Samples

    International Journal of Molecular Sciences, Vol. 25, Núm. 10

  2. Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot study

    British Journal of Dermatology, Vol. 190, Núm. 5, pp. 740-750

  3. Onychocolone A produced by the fungus Onychocola sp. targets cancer stem cells and stops pancreatic cancer progression by inhibiting MEK2-dependent cell signaling

    Biomedicine and Pharmacotherapy, Vol. 177

2023

  1. Pepper fruit, as a nutraceutical food, shows antiproliferative activity against tumor cells and it is potentiatied by nitric oxide (NO)

    Nitric Oxide in Health and Disease: Therapeutic Applications in Cancer and Inflammatory Disorders (Elsevier), pp. 193-210

  2. The Antioxidant Properties of Lavandula multifida Extract Contribute to Its Beneficial Effects in High-Fat Diet-Induced Obesity in Mice

    Antioxidants, Vol. 12, Núm. 4

2022

  1. Impact of the immune response modification by lysophosphatidylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa: LPC therapeutic effect in combined therapy

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 1, pp. 14-21

  2. Insights into the Pharmacokinetics and In Vitro Cell‐Based Studies of the Imidazoline I2 Receptor Ligand B06

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

  3. Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics approach

    Molecular Oncology, Vol. 16, Núm. 14, pp. 2658-2671

2021

  1. Efficacy of Fosfomycin and Its Combination With Aminoglycosides in an Experimental Sepsis Model by Carbapenemase-Producing Klebsiella pneumoniae Clinical Strains

    Frontiers in Medicine, Vol. 8

  2. Human plasma metabolomics for biomarker discovery: Targeting the molecular subtypes in breast cancer

    Cancers, Vol. 13, Núm. 1, pp. 1-18

  3. Identification of compounds with potential therapeutic uses from sweet pepper (Capsicum annuum l.) fruits and their modulation by nitric oxide (no)

    International Journal of Molecular Sciences, Vol. 22, Núm. 9

  4. Metabolomic profile of cancer stem cell-derived exosomes from patients with malignant melanoma

    Molecular Oncology, Vol. 15, Núm. 2, pp. 407-428

  5. Preclinical evaluation of strasseriolides A–D, potent antiplasmodial macrolides isolated from Strasseria geniculata CF-247,251

    Malaria Journal, Vol. 20, Núm. 1

  6. Untargeted metabolomics for the diagnosis of exocrine pancreatic insufficiency in chronic pancreatitis

    Medicina (Lithuania), Vol. 57, Núm. 9

2020

  1. Bisphenol-A in the European Prospective Investigation into Cancer and Nutrition cohort in Spain: Levels at recruitment and associated dietary factors

    Environmental Research, Vol. 182

  2. Discovery of pancreatic adenocarcinoma biomarkers by untargeted metabolomics

    Cancers, Vol. 12, Núm. 4

  3. Metabolomic analysis of Lavandula dentata L. and Lavandula stoechas L. extracts by LC-QTOF/MS experiments and multivariate analysis techniques as a chemotaxonomical tool

    Plant Biosystems, Vol. 154, Núm. 2, pp. 231-240

  4. Novel biomarkers to distinguish between type 3c and type 2 diabetes mellitus by untargeted metabolomics

    Metabolites, Vol. 10, Núm. 11, pp. 1-12

  5. O-Alkyl Hydroxamates Display Potent and Selective Antileishmanial Activity

    Journal of Medicinal Chemistry, Vol. 63, Núm. 11, pp. 5734-5751

  6. Optimization of piperazine-derived ureas privileged structures for effective antiadenovirus agents

    European Journal of Medicinal Chemistry, Vol. 185